skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: ClinicalKey remover Base de dados/Biblioteca: ROAD remover nível superior: Revistas revisadas por pares remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards
Material Type:
Artigo 		Adicionar ao Meu Espaço

Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards

Danesi, R. ; Fogli, S. ; Indraccolo, S. ; Del Re, M. ; Dei Tos, A.P. ; Leoncini, L. ; Antonuzzo, L. ; Bonanno, L. ; Guarneri, V. ; Pierini, A. ; Amunni, G. ; Conte, P.

ESMO open, 2021-04, Vol.6 (2), p.100040-100040, Article 100040 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy

Berardi, R. ; Torniai, M. ; Cona, M.S. ; Cecere, F.L. ; Chiari, R. ; Guarneri, V. ; La Verde, N. ; Locati, L. ; Lorusso, D. ; Martinelli, E. ; Giannarelli, D. ; Garassino, M.C.

ESMO open, 2021-04, Vol.6 (2), p.100053-100053, Article 100053 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
Material Type:
Artigo 		Adicionar ao Meu Espaço

T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study

Schettini, F. ; Conte, B. ; Buono, G. ; De Placido, P. ; Parola, S. ; Griguolo, G. ; Fabi, A. ; Bighin, C. ; Riccardi, F. ; Cianniello, D. ; De Laurentiis, M. ; Puglisi, F. ; Pelizzari, G. ; Bonotto, M. ; Russo, S. ; Frassoldati, A. ; Pazzola, A. ; Montemurro, F. ; Lambertini, M. ; Guarneri, V. ; Cognetti, F. ; Locci, M. ; Generali, D. ; Conte, P. ; De Placido, S. ; Giuliano, M. ; Arpino, G. ; Del Mastro, L.

ESMO open, 2021-04, Vol.6 (2), p.100099-100099, Article 100099 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)

Cortesi, L. ; Venturelli, M. ; Cortesi, G. ; Caggia, F. ; Toss, A. ; Barbieri, E. ; De Giorgi, U. ; Guarneri, V. ; Musolino, A. ; De Matteis, E. ; Zambelli, A. ; Bisagni, G. ; Dominici, M.

ESMO open, 2023-04, Vol.8 (2), p.101207-101207, Article 101207 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
164P Circulating cytokines levels as predictive biomarkers in pleural mesothelioma: Preliminary data from a prospective translational study
164P Circulating cytokines levels as predictive biomarkers in pleural mesothelioma: Preliminary data from a prospective translational study
Material Type:
Artigo 		Adicionar ao Meu Espaço

164P Circulating cytokines levels as predictive biomarkers in pleural mesothelioma: Preliminary data from a prospective translational study

Scattolin, D. ; Urso, L. ; Cavallari, I. ; Ferro, A. ; Maso, A. Dal ; Frega, S. ; Bonanno, L. ; Guarneri, V. ; Pasello, G.

ESMO open, 2024-03, Vol.9, p.102740, Article 102740 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
6
57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors
57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

57P Prognostic impact of functional domain of BRCA1/2 mutation in platinum-sensitive recurrent epithelial ovarian cancer patients receiving PARP inhibitors

Mosimann, F. Stella ; Varano, V. ; Tasca, G. ; Girardi, F. ; Tozzi, R. ; Massa, D. ; Zovato, S. ; Saccardi, C. ; Moserle, L. ; Montagna, M. ; Griguolo, G. ; Guarneri, V.

ESMO open, 2024-06, Vol.9, p.103564, Article 103564 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies

Russo, A. ; Incorvaia, L. ; Capoluongo, E. ; Tagliaferri, P. ; Gori, S. ; Cortesi, L. ; Genuardi, M. ; Turchetti, D. ; De Giorgi, U. ; Di Maio, M. ; Barberis, M. ; Dessena, M. ; Del Re, M. ; Lapini, A. ; Luchini, C. ; Jereczek-Fossa, B.A. ; Sapino, A. ; Cinieri, S. ; Beretta, Giordano ; Bella, Maria Angela ; Bracarda, Sergio ; Colombo, Nicoletta ; Conteduca, Vincenza ; Del Mastro, Lucia ; Galvano, Antonio ; Gristina, Valerio ; Guarneri, Valentina ; La Verde, Nicla ; Lorusso, Domenica ; Marchetti, Paolo ; Normanno, Nicola ; Ottini, Laura ; Pensabene, Matilde ; Pignata, Sandro ; Procopio, Giuseppe ; Ricevuto, Enrico ; Silvestris, Nicola ; Tassone, Pierfrancesco ; Tucci, Marcello ; Donato, Vittorio ; Carrara, Silvia ; Paiella, Salvatore ; Gentilini, Oreste ; Gunelli, Roberta ; Nicolis, Fabrizio ; Buttitta, Fiamma ; Colecchia, Maurizio ; Fassan, Matteo ; Malapelle, Umberto ; Marchetti, Antonio ; Marchiò, Caterina ; Scarpa, Aldo ; Truini, Mauro ; Zamboni, Giuseppe ; Gion, Massimo ; Trevisiol, Chiara ; Gronchi, Alessandro ; Danesi, Romano ; Di Marco, Vito ; Carrera, Paola ; Ghiorzo, Paola ; Pasini, Barbara ; Varesco, Liliana ; Artibani, Walter ; Ludovico, Giuseppe ; Campanella, Ornella ; Vatrano, Simona ; Tagliafico, Enrico

ESMO open, 2022-06, Vol.7 (3), p.100459-100459, Article 100459 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
50P Circulating cytokines to predict pCR to neoadjuvant chemotherapy and nivolumab for ER+/HER2- BC: Analysis of the phase II GIADA trial
50P Circulating cytokines to predict pCR to neoadjuvant chemotherapy and nivolumab for ER+/HER2- BC: Analysis of the phase II GIADA trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

50P Circulating cytokines to predict pCR to neoadjuvant chemotherapy and nivolumab for ER+/HER2- BC: Analysis of the phase II GIADA trial

Dieci, M.V. ; Tosi, A. ; Bicciato, S. ; Bisagni, G. ; Musolino, A. ; Spazzapan, S. ; Vernaci, G.M. ; Griguolo, G. ; Giarratano, T. ; Miglietta, F. ; Urso, L. ; Schiavi, F. ; Pinato, C. ; De Salvo, G. ; Rosato, A. ; Guarneri, V.

ESMO open, 2024-05, Vol.9, p.103057, Article 103057 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
9
33P Breast cancer brain metastases present a suppressed immune microenvironment enriched in macrophagic components as compared to paired primary tumors
33P Breast cancer brain metastases present a suppressed immune microenvironment enriched in macrophagic components as compared to paired primary tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

33P Breast cancer brain metastases present a suppressed immune microenvironment enriched in macrophagic components as compared to paired primary tumors

Griguolo, G. ; Tosi, A. ; Bottosso, M. ; Bauchet, L. ; Zanghi, F. ; Pellegrini, V. ; Miglietta, F. ; Rigau, V. ; Guarascio, M.C. ; Fassan, M. ; Jacot, W. ; Rosato, A. ; Guarneri, V. ; Darlix, A. ; Dieci, M.V.

ESMO open, 2024-05, Vol.9, p.103041, Article 103041 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
10
158TiP Neoadjuvant abemaciclib and giredestrant trial in patients with ER-positive, HER2-negative early breast cancer (GIM31-Neo-AGILE trial)
158TiP Neoadjuvant abemaciclib and giredestrant trial in patients with ER-positive, HER2-negative early breast cancer (GIM31-Neo-AGILE trial)
Material Type:
Artigo 		Adicionar ao Meu Espaço

158TiP Neoadjuvant abemaciclib and giredestrant trial in patients with ER-positive, HER2-negative early breast cancer (GIM31-Neo-AGILE trial)

von Arx, C. ; Calabrese, A. ; Caputo, R. ; Di Lauro, V. ; Pensabene, M. ; Buono, G. ; Fabi, A. ; Cognetti, F. ; Guarneri, V. ; Puglisi, F. ; Vigneri, P. ; Del Mastro, L. ; Arpino, G. ; De Laurentiis, M.

ESMO open, 2024-05, Vol.9, p.103145, Article 103145 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.